CytomX Therapeutics Statistics
Total Valuation
CTMX has a market cap or net worth of $825.15 million. The enterprise value is $687.12 million.
Important Dates
The next confirmed earnings date is Monday, March 16, 2026, before market open.
| Earnings Date | Mar 16, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CTMX has 169.44 million shares outstanding. The number of shares has increased by 41.04% in one year.
| Current Share Class | 169.44M |
| Shares Outstanding | 169.44M |
| Shares Change (YoY) | +41.04% |
| Shares Change (QoQ) | +27.84% |
| Owned by Insiders (%) | 0.52% |
| Owned by Institutions (%) | 64.94% |
| Float | 122.81M |
Valuation Ratios
The trailing PE ratio is 20.33.
| PE Ratio | 20.33 |
| Forward PE | n/a |
| PS Ratio | 7.26 |
| Forward PS | 23.95 |
| PB Ratio | 7.49 |
| P/TBV Ratio | 7.79 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 24.52 |
| EV / Sales | 6.05 |
| EV / EBITDA | 28.02 |
| EV / EBIT | 29.56 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.64, with a Debt / Equity ratio of 0.05.
| Current Ratio | 3.64 |
| Quick Ratio | 3.54 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | 0.20 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 66.76% and return on invested capital (ROIC) is 29.02%.
| Return on Equity (ROE) | 66.76% |
| Return on Assets (ROA) | 9.78% |
| Return on Invested Capital (ROIC) | 29.02% |
| Return on Capital Employed (ROCE) | 19.83% |
| Weighted Average Cost of Capital (WACC) | 17.77% |
| Revenue Per Employee | $939,099 |
| Profits Per Employee | $231,554 |
| Employee Count | 121 |
| Asset Turnover | 0.76 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CTMX has paid $246,000 in taxes.
| Income Tax | 246,000 |
| Effective Tax Rate | 0.87% |
Stock Price Statistics
The stock price has increased by +684.98% in the last 52 weeks. The beta is 2.48, so CTMX's price volatility has been higher than the market average.
| Beta (5Y) | 2.48 |
| 52-Week Price Change | +684.98% |
| 50-Day Moving Average | 5.13 |
| 200-Day Moving Average | 3.47 |
| Relative Strength Index (RSI) | 43.90 |
| Average Volume (20 Days) | 2,715,766 |
Short Selling Information
The latest short interest is 18.86 million, so 11.13% of the outstanding shares have been sold short.
| Short Interest | 18.86M |
| Short Previous Month | 16.96M |
| Short % of Shares Out | 11.13% |
| Short % of Float | 15.36% |
| Short Ratio (days to cover) | 5.98 |
Income Statement
In the last 12 months, CTMX had revenue of $113.63 million and earned $28.02 million in profits. Earnings per share was $0.24.
| Revenue | 113.63M |
| Gross Profit | 113.63M |
| Operating Income | 23.25M |
| Pretax Income | 28.26M |
| Net Income | 28.02M |
| EBITDA | 24.53M |
| EBIT | 23.25M |
| Earnings Per Share (EPS) | $0.24 |
Full Income StatementBalance Sheet
The company has $143.63 million in cash and $5.60 million in debt, with a net cash position of $138.03 million or $0.81 per share.
| Cash & Cash Equivalents | 143.63M |
| Total Debt | 5.60M |
| Net Cash | 138.03M |
| Net Cash Per Share | $0.81 |
| Equity (Book Value) | 107.39M |
| Book Value Per Share | 0.65 |
| Working Capital | 108.19M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$72.25 million and capital expenditures -$99,000, giving a free cash flow of -$72.35 million.
| Operating Cash Flow | -72.25M |
| Capital Expenditures | -99,000 |
| Free Cash Flow | -72.35M |
| FCF Per Share | -$0.43 |
Full Cash Flow StatementMargins
Gross margin is 100.00%, with operating and profit margins of 20.46% and 24.66%.
| Gross Margin | 100.00% |
| Operating Margin | 20.46% |
| Pretax Margin | 24.87% |
| Profit Margin | 24.66% |
| EBITDA Margin | 21.58% |
| EBIT Margin | 20.46% |
| FCF Margin | n/a |
Dividends & Yields
CTMX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -41.04% |
| Shareholder Yield | -41.04% |
| Earnings Yield | 3.40% |
| FCF Yield | -8.77% |
Analyst Forecast
The average price target for CTMX is $8.86, which is 81.93% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $8.86 |
| Price Target Difference | 81.93% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 9.12% |
| EPS Growth Forecast (5Y) | -27.22% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CTMX has an Altman Z-Score of -1.82 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.82 |
| Piotroski F-Score | 4 |
